Home Visits and Telephone-Supported Education for Adults With Type 2 Diabetes
Effects of Home Visits and Telephone-Supported Educational Interventions on Diabetes Knowledge, Self-Care Behaviors, and Diabetes-Related Difficulties in Individuals With Type 2 Diabetes Attending a Family Health Center
This study aims to evaluate the effects of home visits and telephone-supported education on diabetes knowledge, self-care behaviors, and diabetes-related difficulties in adults with type 2 diabetes attending a family health center in Türkiye. The study will examine whether these educational approaches help participants better understand their diabetes, manage daily self-care, and cope with difficulties related to living with diabetes.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Istanbul
-
Istanbul, Istanbul, Turkey (Türkiye), 34035
- Recruiting
- Şehit İbrahim Ceylan Aile Sağlığı Merkezi
-
Contact:
- Rabia Orhanoğlu
- Phone Number: +90 545 737 63 54
- Email: rabiaorhanoglu@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Aged 18-65 years. Diagnosed with type 2 diabetes mellitus for at least 6 months. Able to read and understand Turkish. No health condition that impairs cognition or communication. Owns a smartphone. Uses insulin, oral antidiabetic medication, or both. Willing to participate in the study.
Exclusion Criteria:
Pregnancy. Inability to complete the data collection instruments due to a cognitive or psychiatric condition.
Unwillingness to participate in the study.
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Home Visit-Based Education
Participants in this group will receive nurse-led diabetes education through home visits. The education will focus on diabetes knowledge, daily self-care behaviors, and coping with diabetes-related difficulties. |
A nurse will provide four structured, face-to-face diabetes education sessions in participants' homes, once weekly for four weeks. Each visit will last approximately 45-60 minutes and use PowerPoint presentations, informational brochures, direct instruction, and questions and answers. Weekly topics will cover: (1) diabetes, symptoms, risk factors, complications, hypoglycemia, hyperglycemia, and regular health checks; (2) nutrition, carbohydrate management, food label reading, portion control, and physical activity; (3) medication adherence, insulin use, blood glucose monitoring, foot care, oral care, sleep, and screening; and (4) diabetes-related difficulties, stress management, problem-solving, social support, personal strengths, goal setting, and behavior change. |
|
Experimental: Telephone-Supported Education
Participants in this group will receive nurse-led, telephone-supported diabetes education. The education will focus on diabetes knowledge, daily self-care behaviors, and coping with diabetes-related difficulties. |
A nurse will provide four structured tele-nursing sessions over one month, once weekly, using telephone calls, video calls, and digital educational materials, including PowerPoint presentations and brochures. Each session will last approximately 15-25 minutes, with additional counseling time when needed. The educational content will be similar to that provided to the home visit group. Weekly topics will cover: (1) diabetes, symptoms, risk factors, complications, hypoglycemia, hyperglycemia, and regular health checks; (2) nutrition, carbohydrate management, food label reading, portion control, and physical activity; (3) medication adherence, insulin use, blood glucose monitoring, foot care, oral care, sleep, and screening; and (4) diabetes-related difficulties, stress management, problem-solving, social support, personal strengths, goal setting, and behavior change. Sessions will reinforce learning, support motivation, and address individual self-care needs. |
|
No Intervention: Usual Care Control Group
Participants in this group will continue to receive usual care at the family health center. They will not receive the study-specific home visit-based or telephone-supported educational interventions during the study period. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Diabetes Health-Promoting Self-Care Behaviors
Time Frame: Baseline (before education), immediately after the 4-week education period, and 1 month after completion of education.
|
Changes in self-care behaviors will be assessed using the Turkish version of the Diabetes Health-Promoting Self-Care Scale. The scale includes 27 items across seven domains: interpersonal relationships, personal health responsibility, diet, exercise, foot care, blood glucose self-monitoring, and adherence to the recommended regimen. Each item is scored from 1 to 5, giving a total score of 27-135. Higher scores indicate better health-promoting self-care behaviors. |
Baseline (before education), immediately after the 4-week education period, and 1 month after completion of education.
|
|
Change in Diabetes Knowledge
Time Frame: Baseline (before education), immediately after the 4-week education period, and 1 month after completion of education.
|
Changes in diabetes knowledge will be assessed using the 28-item Adult Diabetes Knowledge Scale developed by Yavuz and Erol. Each correct answer receives 1 point; incorrect and "I do not know" responses receive 0 points. Total scores range from 0 to 28, with higher scores indicating greater diabetes knowledge. |
Baseline (before education), immediately after the 4-week education period, and 1 month after completion of education.
|
|
Change in Diabetes-Related Difficulties
Time Frame: Baseline (before education), immediately after the 4-week education period, and 1 month after completion of education.
|
Changes in diabetes-related difficulties will be assessed using the 30-item Type 2 Diabetes Strengths and Difficulties Scale developed by Bilgehan and Inkaya. The scale assesses difficulties related to lack of knowledge, individual difficulties, and psychosocial difficulties. Each item is scored from 1 (never experience difficulty) to 5 (always experience difficulty), giving a total score of 30-150. Higher scores indicate greater diabetes-related difficulties. |
Baseline (before education), immediately after the 4-week education period, and 1 month after completion of education.
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 26-19
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
There is currently no plan to share individual participant data with other researchers.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.